At the end of the study period, all 15 infants had to have
a favorable safety outcome.
Not exact matches
Concerns about
safety and privacy of human subjects may have contributed to the less
favorable outcomes of clinical research applications.
They don't have a lot of Margin of
Safety and I've been burned too many times before on binary
outcome drug stocks to be really interested unless the upside / downside potential is REALLY
favorable.